GenEdit Competitors and Similar CompaniesClear all
GenEdit's competitors and similar companies include Dyne Therapeutics, Neurogene, Maze Therapeutics and Cimeio.
 GenEdit GenEdit is a company that develops non-viral delivery technologies for the gene-editing system. |  Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases. |  Neurogene Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases. |  Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 2018 | Founding Date 2018 | Founding Date 2018 | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Brisbane, US HQ | Locations Waltham, US HQ | Locations New York, US HQ Houston, US | Locations South San Francisco, US HQ Redwood City, US South San Francisco, US | Locations Basel, CH HQ |
Employees | Employees 562% increase | Employees 1451% decrease | Employees 1091% decrease | Employees 121 | Employees 21 |
Financial | |||||
Net income | Net income N/A | Net income ($446.2m) (FY, 2025) | Net income N/A | Net income ($131.1m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 8.5m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 68.5m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 50m (about 4 years ago) |
Total funding raised | Total funding raised $ 8.5m | Total funding raised $ 165m | Total funding raised $ 68.5m | Total funding raised $ 191m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Dyne Therapeutics
HQ
Waltham, US
Employees
145↓ 1% decrease
Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
View companyNeurogene
HQ
New York, US
Employees
109↓ 1% decrease
Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases.
View company
Maze Therapeutics
HQ
South San Francisco, US
Employees
121
Maze Therapeutics is a clinical-stage biopharmaceutical company.
View companyCimeio
HQ
Basel, CH
Employees
21
Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.
View company